# Covagen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/covagen

- Industry: Pharmaceuticals
- Headquarters: Zurich, Switzerland
- Website: www.covagen.com
- Total disclosed funding: $91M
- Latest round: Series B (Feb 19, 2014)
- Investors on record: 9

## About

Founded in 2007 and based in Zurich, Switzerland, Covagen AG develops protein therapeutics/drugs for the treatment of inflammatory diseases and cancer.

## Funding rounds

- Series B, Feb 19, 2014, $3.2M — Baxter Ventures
- Series B, Dec 9, 2013, $47M — Ventech, Andera Partners, Novartis Venture Fund, Seroba, Gimv, Ascent Biomedical Ventures, MP Healthcare Venture Management
- Series A, Nov 29, 2010, $6.4M — Kernel Capital, Ventech, Andera Partners, Novartis Venture Fund, MP Healthcare Venture Management
- Series A, Dec 1, 2009, $34M — Ventech
- Seed, Oct 5, 2009 — Novartis Venture Fund, MP Healthcare Venture Management

## Investors

- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Seed, Series A, Series B
- MP Healthcare Venture Management (https://capitalatlas.ai/funds/mp-healthcare-venture-management) — Seed, Series A, Series B
- Ventech (https://capitalatlas.ai/funds/ventech) — Series A, Series B
- Kernel Capital (https://capitalatlas.ai/funds/kernel-capital) — Series A
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series A, Series B
- Seroba (https://capitalatlas.ai/funds/seroba) — Series B
- Gimv (https://capitalatlas.ai/funds/gimv) — Series B
- Ascent Biomedical Ventures (https://capitalatlas.ai/funds/ascent-biomedical-ventures) — Series B
- Baxter Ventures (https://capitalatlas.ai/funds/baxter-ventures) — Series B